--(BUSINESS WIRE)--Obsidian Therapeutics, Inc., a clinical-stage biotechnology company pioneering engineered cell and gene therapies, today announced the publication of 3 abstracts for poster ...

A copy of the presentation materials can be accessed on the “ Publication ” section of the Company’s website at www.bioatla.com once the presentations have concluded.

BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally ...

BioAtla, Inc., a biotechnology company specializing in Condition Active Biologic (CAB) antibody therapeutics for solid tumors, announced it will present a poster at the upcoming 2025 ASCO Annual ...